Zusätzliche Mittel für die Sicherheitsüberwachung von COVID-19-Impfstoffen im Zeitraum 2020 bis 2025

This question concerns the allocation of additional funds for monitoring the safety of COVID-19 vaccines between 2020 and 2025. It seeks to understand the financial resources dedicated to ensuring vaccine safety during this period. The focus is on the financial implications for public health authorities responsible for vaccine surveillance. This impacts the resources available for pharmacovigilance activities and public trust in vaccination programs.